- Home
- CFBK vs FBRX Comparison
CFBK vs FBRX Comparison
Compare CFBK & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFBK
- FBRX
- Stock Information
- Founded
- CFBK 1892
- FBRX N/A
- Country
- CFBK United States
- FBRX United States
- Employees
- CFBK N/A
- FBRX N/A
- Industry
- CFBK Major Banks
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- CFBK Finance
- FBRX Health Care
- Exchange
- CFBK Nasdaq
- FBRX Nasdaq
- Market Cap
- CFBK 159.5M
- FBRX 154.5M
- IPO Year
- CFBK 1998
- FBRX N/A
- Fundamental
- Price
- CFBK $24.30
- FBRX $11.96
- Analyst Decision
- CFBK Buy
- FBRX Strong Buy
- Analyst Count
- CFBK 1
- FBRX 3
- Target Price
- CFBK $29.00
- FBRX $68.00
- AVG Volume (30 Days)
- CFBK 33.9K
- FBRX 79.4K
- Earning Date
- CFBK 10-29-2025
- FBRX 11-13-2025
- Dividend Yield
- CFBK 1.30%
- FBRX N/A
- EPS Growth
- CFBK 36.66
- FBRX N/A
- EPS
- CFBK 2.77
- FBRX N/A
- Revenue
- CFBK $52,793,000.00
- FBRX N/A
- Revenue This Year
- CFBK $39.98
- FBRX N/A
- Revenue Next Year
- CFBK $10.47
- FBRX N/A
- P/E Ratio
- CFBK $8.88
- FBRX N/A
- Revenue Growth
- CFBK 20.91
- FBRX N/A
- 52 Week Low
- CFBK $19.23
- FBRX $4.11
- 52 Week High
- CFBK $31.17
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- CFBK 43.20
- FBRX 59.36
- Support Level
- CFBK $24.80
- FBRX $10.11
- Resistance Level
- CFBK $25.80
- FBRX $11.57
- Average True Range (ATR)
- CFBK 0.53
- FBRX 0.84
- MACD
- CFBK -0.06
- FBRX 0.09
- Stochastic Oscillator
- CFBK 1.18
- FBRX 78.22
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).